Amy Abernethy, MD, PhD
Hematologist/oncologist and palliative medicine physician who co-leads an organization focused on dramatically accelerating timelines for understanding what clinical interventions work for whom and when. Her areas of research and expertise include cancer data, real world evidence, clinical trials, healthcare policy and regulation, health services research, patient-reported outcomes (PROs), clinical informatics, and patient-centered care. Amy was professor of medicine at Duke, principal deputy commissioner of the FDA and chief medical officer at Verily and Flatiron Health.